tiprankstipranks
Trending News
More News >
Bal Pharma Limited (IN:BALPHARMA)
:BALPHARMA
India Market

Bal Pharma Limited (BALPHARMA) Financial Statements

Compare
0 Followers

Bal Pharma Limited Financial Overview

Bal Pharma Limited's market cap is currently ₹1.58B. The company's EPS TTM is ₹3.4; its P/E ratio is 21.71; and it has a dividend yield of 1.21%. Bal Pharma Limited is scheduled to report earnings on May 29, 2025, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 25Mar 24Mar 23Mar 22Mar 21
Income Statement
Total Revenue₹ 3.03B₹ 3.39B₹ 3.04B₹ 2.81B₹ 2.51B
Gross Profit₹ 730.18M₹ 770.20M₹ 1.31B₹ 1.11B₹ 993.03M
Operating Income₹ 197.89M₹ 214.57M₹ 169.35M₹ 144.36M₹ 170.88M
EBITDA₹ 317.63M₹ 320.23M₹ 245.00M₹ 287.64M₹ 257.82M
Net Income₹ 72.15M₹ 73.92M₹ 25.72M₹ 56.12M₹ 47.42M
Balance Sheet
Cash & Short-Term Investments₹ 105.19M₹ 199.29M₹ 90.81M₹ 60.84M₹ 39.71M
Total Assets₹ 3.36B₹ 3.20B₹ 3.13B₹ 2.61B₹ 2.40B
Total Debt₹ 1.50B₹ 1.42B₹ 1.31B₹ 1.07B₹ 1.12B
Net Debt₹ 1.42B₹ 1.38B₹ 1.30B₹ 1.06B₹ 1.11B
Total Liabilities₹ 2.58B₹ 2.50B₹ 2.49B₹ 2.02B₹ 1.87B
Stockholders' Equity₹ 774.16M₹ 692.94M₹ 637.89M₹ 586.27M₹ 535.81M
Cash Flow
Free Cash Flow₹ -145.55M₹ 118.26M₹ -164.89M₹ 192.39M₹ 183.68M
Operating Cash Flow₹ 42.32M₹ 228.06M₹ -18.43M₹ 277.08M₹ 217.81M
Investing Cash Flow₹ -156.53M₹ -188.91M₹ -221.82M₹ -94.85M₹ -49.80M
Financing Cash Flow₹ 90.12M₹ -12.06M₹ 244.00M₹ -181.34M₹ -166.32M
Currency in INR

Bal Pharma Limited Earnings and Revenue History

Bal Pharma Limited Debt to Assets

Bal Pharma Limited Cash Flow

Bal Pharma Limited Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis